Skip to main content

DisclosureWe earn commission on partner links. Read policy

HealthVetted
Nootropics & focus · Ingredient

Citicoline (CDP-choline)

BModerate evidenceHow we grade evidence
Research snapshot1source cited2021evidence window

What it is

An intermediate in phosphatidylcholine synthesis that supplies choline for acetylcholine and supports neuronal membrane integrity.

What the evidence says

Evidence is promising but limited. A 2021 randomized, double-blind, placebo-controlled trial in The Journal of Nutrition (n=100, ages 50-85 with age-associated memory impairment) found 500 mg/day for 12 weeks significantly improved episodic and composite memory versus placebo. Other small studies report attention benefits. However, trials are few, often industry-funded, and there is little data in healthy younger adults, so larger confirmatory trials are needed.

Typical dose in trials

250-500 mg/day; the strongest trial used 500 mg/day for 12 weeks.

Educational summary of doses studied — not a recommendation. Talk to a clinician before starting any supplement.

Shopping for it?
See our nootropics & focus rankings

Sources (1)

  1. Citicoline and Memory Function in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial — The Journal of Nutrition (PMC8349115) (2021)
More nootropics & focus ingredients

Educational summary of published research, checked against primary sources and linked inline. Not medical advice; supplements are not FDA-evaluated to treat disease. See our editorial policy.